|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0021079,
umls-concept:C0021080,
umls-concept:C0024314,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0205265,
umls-concept:C0220901,
umls-concept:C0301630,
umls-concept:C0439828,
umls-concept:C0936012,
umls-concept:C1517942,
umls-concept:C1555582
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2001-5-25
|
|
pubmed:abstractText |
Posttransplant lymphoproliferative disorder (PTLD) is an Epstein-Barr virus-associated malignancy that occurs in the setting of pharmacologic immunosuppression after organ transplantation. With the increased use of organ transplantation and intensive immunosuppression, this disease is becoming more common. We explore reduction in immunosuppression as an initial therapy for PTLD.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1076-88
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11374406-Adolescent,
pubmed-meshheading:11374406-Adult,
pubmed-meshheading:11374406-African Continental Ancestry Group,
pubmed-meshheading:11374406-Aged,
pubmed-meshheading:11374406-Antiviral Agents,
pubmed-meshheading:11374406-Databases, Factual,
pubmed-meshheading:11374406-European Continental Ancestry Group,
pubmed-meshheading:11374406-Female,
pubmed-meshheading:11374406-Follow-Up Studies,
pubmed-meshheading:11374406-Humans,
pubmed-meshheading:11374406-Immunosuppressive Agents,
pubmed-meshheading:11374406-Lymphoproliferative Disorders,
pubmed-meshheading:11374406-Male,
pubmed-meshheading:11374406-Middle Aged,
pubmed-meshheading:11374406-Multivariate Analysis,
pubmed-meshheading:11374406-Organ Transplantation,
pubmed-meshheading:11374406-Pennsylvania,
pubmed-meshheading:11374406-Postoperative Complications,
pubmed-meshheading:11374406-Prognosis,
pubmed-meshheading:11374406-Retrospective Studies,
pubmed-meshheading:11374406-Survival Rate,
pubmed-meshheading:11374406-Time Factors
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients.
|
|
pubmed:affiliation |
Hematologic Malignancies Program, University of Pennsylvania Cancer Center, Philadelphia 19104, USA. detsai@mail.med.upenn.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
